![Efficiency of extraction and conversion of pseudoephedrine to methamphetamine from tamper‐resistant and non‐tamper‐resistant formulations | Semantic Scholar Efficiency of extraction and conversion of pseudoephedrine to methamphetamine from tamper‐resistant and non‐tamper‐resistant formulations | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/29095c5bf3940953cc95cec14442e91b6adb17c6/4-Table1-1.png)
Efficiency of extraction and conversion of pseudoephedrine to methamphetamine from tamper‐resistant and non‐tamper‐resistant formulations | Semantic Scholar
![The effect of a potentially tamper-resistant oxycodone formulation on opioid use and harm: main findings of the National Opioid Medications Abuse Deterrence (NOMAD) study - The Lancet Psychiatry The effect of a potentially tamper-resistant oxycodone formulation on opioid use and harm: main findings of the National Opioid Medications Abuse Deterrence (NOMAD) study - The Lancet Psychiatry](https://www.thelancet.com/cms/attachment/319c9f5d-0b5e-4b4e-aa32-3a7481a7e58c/gr2_lrg.jpg)
The effect of a potentially tamper-resistant oxycodone formulation on opioid use and harm: main findings of the National Opioid Medications Abuse Deterrence (NOMAD) study - The Lancet Psychiatry
![A comparison among tapentadol tamper‐resistant formulations (TRF) and OxyContin® (non‐TRF) in prescription opioid abusers - Vosburg - 2013 - Addiction - Wiley Online Library A comparison among tapentadol tamper‐resistant formulations (TRF) and OxyContin® (non‐TRF) in prescription opioid abusers - Vosburg - 2013 - Addiction - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/96785f54-cce6-4e99-a0f1-8883fe8db0b5/add12114-fig-0002-m.jpg)
A comparison among tapentadol tamper‐resistant formulations (TRF) and OxyContin® (non‐TRF) in prescription opioid abusers - Vosburg - 2013 - Addiction - Wiley Online Library
![The effect of a potentially tamper-resistant oxycodone formulation on opioid use and harm: main findings of the National Opioid Medications Abuse Deterrence (NOMAD) study - The Lancet Psychiatry The effect of a potentially tamper-resistant oxycodone formulation on opioid use and harm: main findings of the National Opioid Medications Abuse Deterrence (NOMAD) study - The Lancet Psychiatry](https://www.thelancet.com/cms/attachment/6dd392e4-7146-4460-808b-2405e29277f6/gr3.jpg)
The effect of a potentially tamper-resistant oxycodone formulation on opioid use and harm: main findings of the National Opioid Medications Abuse Deterrence (NOMAD) study - The Lancet Psychiatry
![ABUSE DETERRENT TECHNOLOGY - New Abuse Deterrent Formulation Technology for Immediate-Release Opioids ABUSE DETERRENT TECHNOLOGY - New Abuse Deterrent Formulation Technology for Immediate-Release Opioids](https://d2akihtr51eb46.cloudfront.net/wp-content/uploads/2013/10/F5.jpg)
ABUSE DETERRENT TECHNOLOGY - New Abuse Deterrent Formulation Technology for Immediate-Release Opioids
![The effect of a potentially tamper-resistant oxycodone formulation on opioid use and harm: main findings of the National Opioid Medications Abuse Deterrence (NOMAD) study - The Lancet Psychiatry The effect of a potentially tamper-resistant oxycodone formulation on opioid use and harm: main findings of the National Opioid Medications Abuse Deterrence (NOMAD) study - The Lancet Psychiatry](https://www.thelancet.com/cms/attachment/90785987-3cca-4f52-994e-52d1ebb6ca84/gr1.jpg)
The effect of a potentially tamper-resistant oxycodone formulation on opioid use and harm: main findings of the National Opioid Medications Abuse Deterrence (NOMAD) study - The Lancet Psychiatry
![PDF) Person-level changes in oxycodone use after the introduction of a tamper-resistant formulation in Australia PDF) Person-level changes in oxycodone use after the introduction of a tamper-resistant formulation in Australia](https://www.researchgate.net/profile/Andrea-Schaffer/publication/324006183/figure/fig2/AS:631577553952807@1527591231861/figure-fig2_Q320.jpg)